Published date: 8 June 2020
This notice was replaced on 9 February 2021
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Awarded contract (published 9 February 2021)
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Chemical products - 24000000
Pharmaceutical products - 33600000
Location of contract
North East
Value of contract
£1,000,000
Procurement reference
1772
Published date
8 June 2020
Closing date
23 June 2020
Contract start date
7 July 2020
Contract end date
5 July 2024
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
This is an accelerated procedure.
Justification
The COVID-19 outbreak has given rise to an urgent need for the supply of nucleotides because of their use in vaccine development in response to COVID-19. This does not give CPI sufficient time to comply with the standard open procedure timescales for this procurement. CPI considers this to be a state of urgency which it has duly substantiated. Accordingly, CPI is using the accelerated time limits permitted under the Public Contract Regulations 2015 (regulation [27(5)) in respect of this procurement.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
In response to the COVID-19 Vaccine manufacture programme, CPI need to secure supply of Nucleotides tohelp develop a self-amplifying RNA Vaccine. For more information please see the tender documents at https://ne1procurementservices.com/
About the buyer
Contact name
CPI Procurement
Address
Wilton
REDCAR
TS104RF
England
Telephone
01740 625716
Share this notice
All content is available under the
